Mert Akbas

Prof. Dr. Mert Akbas


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 May 2011 in Journal of Back and Musculoskeletal Rehabilitation
Verified
Journal Article
Closed access
PDF file
MAMert Akbas
Mert Akbas
NLNurettin Luleci
Nurettin Luleci
KDKamer Dere
Kamer Dere
ELEmel Luleci
Emel Luleci
UOUgur Ozdemir
Ugur Ozdemir
HTHuseyin Toman
Huseyin Toman
Background and objective: We studied the long-term efficacy of pulsed radiofrequency treatment (PRF) on the saphenous nerve in 115 patients with chronic knee pain. Materials and methods: 115 patients with chronic knee pain were investigated in a peri

1 January 2016 in Ağrı - The Journal of The Turkish Society of Algology
Verified
Journal Article
Closed access
MAMert Akbas
Mert Akbas
Spinal cord stimulation as treatment of chronic low back pain via neuromodulation has been frequently performed in recent years. The dorsal column is stimulated by an electrode placed at the epidural region. In the case presently described, subcutaneous lead was implanted in a patient with failed back syndrome after spinal cord stimulation was inadequate to treat back and gluteal pain. A 65-year-old male had undergone surgery to treat lumbar disc herniation, after which he received physical therapy and multiple steroid injections due to unrelieved pain. He was admitted to the pain clinic with pain radiating to right gluteal muscle and leg. Spinal cord stimulation was performed and, as pain was not relieved, subcutaneous lead was applied to the right cluneal nerve distribution. Following treatment, the patient scored 1-2 on visual analog scale. Pain had been reduced by over 80%. Octad electrode was placed between T8 and T10 vertebrae after Tuohy needle was introduced to intervertebral area between L1 and L2. Paresthesia occurred in the right extremity. Boundaries were determined by area of right gluteal region in which paresthesia did not occur. Octad electrode was placed subcutaneously after vertical line was drawn from center point. Paresthesia occurred throughout the region. Pulse wave was 390-450 msec; frequency was 10-30 Hz. Subcutaneous electrode replacement is effective additional therapy when pain is not relieved by spinal cord stimulation.



1 January 2015 in Ağrı - The Journal of The Turkish Society of Algology
Verified
Journal Article
Closed access
MAMert Akbas
Mert Akbas

23 October 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
GDGozde Dağıstan
Gozde Dağıstan
FBFatih Kursad Bahcivan
Fatih Kursad Bahcivan
NKNurten Kayacan
Nurten Kayacan
MAMert Akbas
Mert Akbas
BKBilge Karsli
Bilge Karsli
Background: Severe cancer-related pain remains a major clinical challenge in patients with advanced malignancies and may persist despite multimodal analgesic treatment. Objective: This study evaluated short-term clinical outcomes and complications associated with computed tomography (CT)-guided percutaneous cordotomy for severe, unilateral cancer-related pain. Design: This retrospective single-center case series included 21 patients with treatment-refractory cancer pain who underwent CT-guided cordotomy between 2019 and 2024. Pain intensity, functional status, and opioid consumption were assessed at baseline and at the standardized 1-month follow-up using the Visual Analog Scale (VAS), Karnofsky Performance Status (KPS), and daily morphine milligram equivalents (MME), respectively. Results: At 1 month, the mean VAS score decreased from 9.95 to 0.90 (p < 0.001), mean daily MME decreased from 876.00 to 205.62 mg/day (p < 0.001), and mean KPS increased from 38.10 to 69.52 (p < 0.001). No permanent or major complications were documented during the available 1-month follow-up. Conclusions: In this retrospective single-center case series, CT-guided percutaneous cordotomy was associated with marked short-term reductions in pain intensity and opioid requirements and improvement in functional status at 1 month in patients with severe, unilateral cancer pain refractory to conventional therapy. Given the small sample size, absence of a control group, and limited follow-up duration, these findings should be considered preliminary and should not be interpreted as establishing definitive efficacy or safety.